Gates, Merck fight AIDS in Botswana
Six years ago, Botswana had the highest HIV prevalence in the world. Nearly two in five adults ? as many as three in five in some regions ? were HIV-positive, and in less than a decade, life expectancy had crashed from the mid-60s to slightly over 30 years.In a lecture yesterday, Jeff Sturchio '73, vice-president of External Affairs in Europe, the Middle East, Africa and Canada at Merck Pharmaceuticals, and Todd Summers, senior policy officer for the Bill and Melinda Gates Foundation, discussed the work their organizations have done to fight AIDS.The Gates Foundation and Merck Company Foundation have each committed more than $50 million in five years to combat the prevalence of HIV in Botswana, launching the African Comprehensive HIV/AIDS Partnerships (ACHAP), the world's first country-based program to fight the disease.Begun in January 2001 and set to run until December 2009, ACHAP focuses on Botswana both because of its severe HIV/AIDS problem and its small population and comparatively high income and literacy rates, factors that contributed to the success of the program.Sturchio and Summers explained ACHAP's "three-pronged attack" on AIDS, which focuses on prevention, counseling and testing, and treatment for those who are already HIV-positive.Prevention has included the national distribution of millions of condoms from nearly 2,000 dispensers in as many as 10 districts.




